End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-03 | Windtree Therapeutics, Inc. announced that it expects to receive $0.2 million in funding | CI |
06-26 | Windtree Therapeutics, Inc. announced that it expects to receive $35 million in funding | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 14-05-19 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 13-10-31 |
Diane Carman
LAW | General Counsel | 55 | 21-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 591,909 | 568,154 ( 95.99 %) | 0 ( 0.000009 %) | 95.99 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.com![address DIS LAB USD0.001](https://cdn.zonebourse.com/static/address/9089.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- WINT Stock
- Stock
- Company DIS LAB USD0.001